Castle Creek Arbitrage’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Castle Creek Arbitrage’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-714,339	Closed	-$7.15M	–	774
2022 Q3	$7.15M	Hold	714,339	–	–	0.4%	65
2022 Q2	$7.07M	Hold	714,339	–	–	0.39%	66
2022 Q1	$7.04M	Hold	714,339	–	–	0.35%	75
2021 Q4	$7M	Hold	714,339	–	–	0.35%	75
2021 Q3	$7.01M	Hold	714,339	–	–	0.4%	67
2021 Q2	$7.07M	Hold	714,339	–	–	0.39%	63
2021 Q1	$7.33M	Buy	714,339 +3,000	+0.4%	+$33.3K	0.43%	55
2020 Q4	$7.65M	Buy	+711,339	New	+$7.62M	0.47%	53

Castle Creek Arbitrage's LUXA Position: Q4 2022 in Review

Castle Creek Arbitrage sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 714,339 shares — an estimated $7.15M sold.

Castle Creek Arbitrage first reported a position in LUXA in Q4 2020 and held it in 8 quarters. The position peaked at $7.65M in Q4 2020. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

Castle Creek Arbitrage reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Castle Creek Arbitrage sold 714,339 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $7.15M.
Castle Creek Arbitrage first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q4 2020 and held it in 8 quarters.
Castle Creek Arbitrage's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $7.65M in Q4 2020.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Castle Creek Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.